{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:27:25Z","timestamp":1790684845757,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science Foundation Ireland Cluster","award":["07-SRC-B1154"],"award-info":[{"award-number":["07-SRC-B1154"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jconrel.2016.07.047","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T20:49:26Z","timestamp":1469911766000},"page":"242-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage"],"prefix":"10.1016","volume":"238","author":[{"given":"Tanira A.S.","family":"Aguirre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia S.","family":"Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana R.","family":"Pohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8781-8344","authenticated-orcid":false,"given":"David J.","family":"Brayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.07.047_bb0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4155\/tde.14.111","article-title":"Challenges in the delivery of peptide drugs: an industry perspective","volume":"6","author":"Lewis","year":"2015","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejps.2015.09.001","article-title":"In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill\u00ae) of salmon calcitonin","volume":"79","author":"Aguirre","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0015","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jbmr.1602","article-title":"A Phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.","volume":"27","author":"Binkley","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0020","article-title":"European Medicines Agency recommends restricting use of trimetazidine-containing medicines","author":"European Medicines Agency","year":"2012","journal-title":"Eur. Med. Agency"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0025","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00198-014-2796-0","article-title":"Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial","volume":"25","author":"Binkley","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0030","author":"Depakote (divalproex sodium) tablets - product label."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0035","author":"EMBEDA\u00ae - product label."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11094-011-0618-7","article-title":"Interpolymer combinations of chemically complementary grades of Eudragit copolymers: a new direction in the design of peroral solid dosage forms of drug delivery systems with controlled release (review)","volume":"45","author":"Mustafin","year":"2011","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2011.10.017","article-title":"Duodenum-specific drug delivery: in vivo assessment of a pharmaceutically developed enteric-coated capsule for a broad applicability in rat studies","volume":"422","author":"Reix","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0050","first-page":"1","article-title":"Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres","author":"Keohane","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0055","first-page":"1","article-title":"Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study","volume":"304258","author":"Travis","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0060","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1208\/s12249-015-0350-9","article-title":"Colon-targeted oral drug delivery systems: design trends and approaches","volume":"16","author":"Amidon","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0100","series-title":"Composition Comprising Oil Drops","author":"Coulter","year":"2010"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0065","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","article-title":"Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic","volume":"61","author":"Maher","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ejpb.2014.10.013","article-title":"Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models","volume":"88","author":"Aguirre","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0075","unstructured":"Food additives permitted for direct addition to food for human consumption, Sec. 172.863 Salts of Fatty Acids, (n.d.). http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=172.863 (accessed November 26, 2015)."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0080","unstructured":"Agency Response Letter GRAS Notice No. GRN 000237, (n.d.)7. http:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/GRAS\/NoticeInventory\/ucm153914.htm (accessed November 26, 2015)."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0085","series-title":"Cleaning composition with decyl and coco glucosides","author":"Petechin","year":"2013"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jconrel.2005.05.016","article-title":"Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts","volume":"106","author":"Song","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0095","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejpb.2013.12.017","article-title":"The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition","volume":"86","author":"Welling","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(01)00871-7","article-title":"Enteric coated HPMC capsules designed to achieve intestinal targeting","volume":"231","author":"Cole","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00137696-200503030-00003","article-title":"Polymer colon drug delivery systems and their application to peptides, proteins, and nucleic acids","volume":"3","author":"Bourgeois","year":"2005","journal-title":"Am. J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0115","series-title":"Oral delivery of salmon calcitonin using a novel liquid emulsion drug delivery system (LEDDSTM)","author":"Aguirre","year":"2013"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0120","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1021\/js960473x","article-title":"Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets","volume":"86","author":"Polli","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0125","author":"ICH"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0130","series-title":"Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications","author":"Gabrielsson","year":"2000"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanisms of solute release from porous hydrophilic polymers","volume":"15","author":"Korsmeyer","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0145","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","article-title":"A simple equation for description of solute release II. Fickian and anomalous release from swellable devices","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/1520-6017(200104)90:4<464::AID-JPS1004>3.0.CO;2-C","article-title":"Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy","volume":"90","author":"Haruta","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0160","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1023\/A:1012161630481","article-title":"Simultaneous in vivo visualization and localization of solid oral dosage forms in the rat gastrointestinal tract by magnetic resonance imaging (MRI)","volume":"14","author":"Christmann","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0165","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/bc100478k","article-title":"Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging","volume":"22","author":"Andreozzi","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0170","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2011.10.017","article-title":"Duodenum-specific drug delivery: in vivo assessment of a pharmaceutically developed enteric-coated capsule for a broad applicability in rat studies","volume":"422","author":"Reix","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0175","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2010.01.001","article-title":"Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imaging","volume":"388","author":"Saphier","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2006.06.023","article-title":"Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection","volume":"115","author":"Albrecht","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2982.2008.01179.x","article-title":"Ghrelin regulates gastric phase III-like contractions in freely moving conscious mice","volume":"21","author":"Zheng","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0190","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejpb.2007.01.013","article-title":"Preparation and characterization of free mixed-film of pectin\/chitosan\/Eudragit RS intended for sigmoidal drug delivery","volume":"67","author":"Ghaffari","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(03)00003-6","article-title":"The influence of drug type on the release profiles from Surelease-coated pellets","volume":"254","author":"Sadeghi","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0200","series-title":"Pectins and Pectinases","article-title":"Metabolism of pectin in the gastrointestinal tract","author":"Dongowski","year":"1995"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0205","doi-asserted-by":"crossref","DOI":"10.1208\/pt0804088","article-title":"Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate","volume":"8","author":"Avachat","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijpharm.2005.07.022","article-title":"Formulation study and drug release mechanism of a new theophylline sustained-release preparation","volume":"304","author":"Hayashi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2008.12.014","article-title":"Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate","volume":"135","author":"Ryan","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2010.10.004","article-title":"PK\/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights","volume":"149","author":"Ryan","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jconrel.2010.07.128","article-title":"In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes","volume":"147","author":"Cheng","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0230","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1023\/A:1015839719618","article-title":"Degradation of synthetic salmon calcitonin in aqueous solution","volume":"9","author":"K\u00b7C","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0235","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.ddtec.2011.11.006","article-title":"Overcoming poor permeability: translating permeation enhancers for oral peptide delivery","volume":"9","author":"Maher","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1018819012405","article-title":"Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon","volume":"16","author":"Sinko","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2011.02.061","article-title":"Comparison of in vitro and in vivo performance of a colonic delivery system","volume":"409","author":"Ahmed","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0250","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1051\/rnd:19800713","article-title":"The adaptation of digestive enzymes to the diet: its physiological significance","volume":"20","author":"Corring","year":"1980","journal-title":"Reprod. Nutr. Dev."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0255","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/oxfordjournals.jbchem.a131312","article-title":"Circadian rhythms of digestive enzymes in the small intestine of the rat II. Effects of fasting and refeeding","volume":"80","author":"Saito","year":"1976","journal-title":"J. Biochem."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0260","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4155\/tde.12.79","article-title":"Peptide therapeutics: it's all in the delivery","volume":"3","author":"Grant","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0265","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/03639040903173580","article-title":"Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats","volume":"36","author":"Wu","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejpb.2012.12.011","article-title":"PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery","volume":"84","author":"Licciardi","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0275","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1359\/jbmr.2002.17.8.1478","article-title":"Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers","volume":"17","author":"Buclin","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jconrel.2016.07.047_bb0280","article-title":"Oral peptide pharmaceutical products","volume":"6086918","author":"Stern","year":"2000","journal-title":"US patent"},{"key":"10.1016\/j.jconrel.2016.07.047_bb0285","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0091270010372625","article-title":"Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials","volume":"51","author":"Karsdal","year":"2011","journal-title":"J. Clin. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591630493X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591630493X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T15:13:41Z","timestamp":1572534821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591630493X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":57,"alternative-id":["S016836591630493X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.047","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.07.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}